Reconsidération du risque de transmission de maladies infectieuses par la transfusion sanguine
暂无分享,去创建一个
[1] D. Slamon,et al. Seroprevalence and epidemiological correlates of HTLV-I infection in U.S. blood donors. , 1988, Science.
[2] A. Widell,et al. Relation between Donor Transaminase and Recipient Hepatitis Non‐A, Non‐B in Sweden , 1988, Vox sanguinis.
[3] S. Gayet,et al. Post‐Transfusion Non‐A, Non‐B Hepatitis after Cardiac Surgery , 1986, Vox sanguinis.
[4] L. Matter,et al. The risk of transmitting cytomegalovirus to patients receiving blood transfusions. , 1986, The Journal of infectious diseases.
[5] N. Flournoy,et al. Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. , 1986, The New England journal of medicine.
[6] M. Miller,et al. Molecular epidemiology of cytomegalovirus infections associated with bone marrow transplantation. , 1985, Annals of internal medicine.
[7] R. Purcell,et al. Donor transaminase and recipient hepatitis. Impact on blood transfusion services. , 1981, JAMA.
[8] Pask Ea,et al. HOMOSEXUALITY AS A CRIME. , 1965 .
[9] E. Pask,et al. BORRELIDIN AND VIVOMYCIN. , 1965, Lancet.
[10] Simpson Ca. ADAPTATION TO THE DESERT. , 1964 .